Medtronic ROE 2010-2024 | MDT
Medtronic ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2024-01-31 | $4.20B | $52.00B | 8.13% |
2023-10-31 | $4.10B | $51.65B | 7.95% |
2023-07-31 | $3.62B | $51.37B | 7.01% |
2023-04-30 | $3.76B | $51.67B | 7.22% |
2023-01-31 | $4.06B | $51.62B | 7.77% |
2022-10-31 | $4.32B | $52.06B | 8.22% |
2022-07-31 | $5.21B | $52.84B | 9.89% |
2022-04-30 | $5.04B | $52.72B | 9.63% |
2022-01-31 | $4.91B | $52.71B | 9.44% |
2021-10-31 | $4.70B | $52.16B | 9.12% |
2021-07-31 | $3.88B | $51.66B | 7.59% |
2021-04-30 | $3.61B | $51.60B | 7.10% |
2021-01-31 | $2.89B | $50.93B | 5.71% |
2020-10-31 | $3.54B | $50.32B | 6.95% |
2020-07-31 | $4.41B | $50.44B | 8.65% |
2020-04-30 | $4.79B | $50.87B | 9.39% |
2020-01-31 | $5.32B | $51.95B | 10.45% |
2019-10-31 | $4.67B | $50.72B | 9.27% |
2019-07-31 | $4.42B | $50.50B | 8.82% |
2019-04-30 | $4.63B | $50.21B | 9.25% |
2019-01-31 | $4.92B | $49.94B | 9.80% |
2018-10-31 | $2.26B | $49.71B | 4.49% |
2018-07-31 | $3.16B | $50.33B | 6.23% |
2018-04-30 | $3.10B | $50.82B | 6.10% |
2018-01-31 | $2.81B | $50.34B | 5.53% |
2017-10-31 | $5.02B | $51.58B | 9.93% |
2017-07-31 | $4.12B | $50.79B | 8.19% |
2017-04-30 | $4.03B | $50.33B | 8.02% |
2017-01-31 | $3.97B | $49.49B | 7.83% |
2016-10-31 | $4.24B | $50.29B | 8.32% |
2016-07-31 | $3.65B | $50.89B | 7.08% |
2016-04-30 | $3.54B | $52.06B | 6.81% |
2016-01-31 | $2.43B | $50.82B | 4.66% |
2015-10-31 | $2.32B | $52.27B | 5.19% |
2015-07-31 | $2.62B | $52.81B | 7.21% |
2015-04-30 | $2.68B | $53.23B | 9.55% |
2015-01-31 | $3.12B | $20.17B | 15.96% |
2014-10-31 | $2.91B | $19.44B | 15.02% |
2014-07-31 | $2.98B | $19.25B | 15.54% |
2014-04-30 | $3.07B | $19.44B | 16.12% |
2014-01-31 | $3.59B | $19.35B | 19.05% |
2013-10-31 | $3.81B | $18.74B | 20.67% |
2013-07-31 | $3.56B | $18.52B | 19.70% |
2013-04-30 | $3.47B | $18.67B | 19.55% |
2013-01-31 | $3.49B | $17.84B | 20.11% |
2012-10-31 | $3.44B | $17.18B | 20.00% |
2012-07-31 | $3.66B | $17.26B | 21.44% |
2012-04-30 | $3.62B | $17.11B | 21.48% |
2012-01-31 | $3.40B | $17.17B | 20.56% |
2011-10-31 | $3.39B | $16.74B | 21.07% |
2011-07-31 | $3.09B | $16.34B | 19.76% |
2011-04-30 | $3.10B | $15.97B | 20.38% |
2011-01-31 | $3.28B | $15.36B | 22.05% |
2010-10-31 | $3.18B | $14.83B | 21.80% |
2010-07-31 | $3.48B | $14.60B | 24.38% |
2010-04-30 | $3.10B | $14.63B | 22.25% |
2010-01-31 | $2.25B | $14.32B | 16.56% |
2009-10-31 | $2.11B | $13.61B | 15.95% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $105.230B | $31.227B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $185.422B | 24.34 |
Stryker (SYK) | United States | $128.275B | 31.81 |
Boston Scientific (BSX) | United States | $107.479B | 34.23 |
EssilorLuxottica (ESLOY) | France | $98.467B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $42.075B | 0.00 |
Haleon (HLN) | United Kingdom | $38.356B | 30.00 |
ResMed (RMD) | United States | $26.979B | 25.30 |
Terumo (TRUMY) | Japan | $24.775B | 34.99 |
Zimmer Biomet Holdings (ZBH) | United States | $24.604B | 15.84 |
Baxter (BAX) | United States | $20.430B | 14.90 |
Koninklijke Philips (PHG) | Netherlands | $19.242B | 15.35 |
Insulet (PODD) | United States | $11.496B | 60.36 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.440B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.860B | 23.42 |
BellRing Brands (BRBR) | United States | $7.238B | 38.92 |
Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
Haemonetics (HAE) | United States | $4.452B | 22.77 |
Perrigo (PRGO) | Ireland | $4.238B | 12.12 |
GN Store Nord (GNNDY) | Denmark | $3.889B | 25.18 |
Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.47 |
Envista Holdings (NVST) | United States | $3.441B | 13.09 |
QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
Neogen (NEOG) | United States | $2.591B | 24.92 |
Green Thumb Industries (GTBIF) | United States | $2.482B | 78.67 |
ICU Medical (ICUI) | United States | $2.303B | 17.19 |
TG Therapeutics (TGTX) | United States | $2.150B | 695.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.906B | 0.00 |
Owens & Minor (OMI) | United States | $1.848B | 17.74 |
Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.617B | 0.00 |
InMode (INMD) | Israel | $1.429B | 7.40 |
LeMaitre Vascular (LMAT) | United States | $1.414B | 46.66 |
National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
AdaptHealth (AHCO) | United States | $1.273B | 9.58 |
Warby Parker (WRBY) | United States | $1.254B | 0.00 |
AtriCure (ATRC) | United States | $1.094B | 0.00 |
MacroGenics (MGNX) | United States | $0.899B | 0.00 |
Canopy Growth (CGC) | Canada | $0.872B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.764B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.686B | 14.82 |
Cresco Labs (CRLBF) | United States | $0.674B | 0.00 |
Evolus (EOLS) | United States | $0.664B | 0.00 |
Jin Medical (ZJYL) | China | $0.608B | 0.00 |
Quanterix (QTRX) | United States | $0.596B | 0.00 |
Valneva SE (VALN) | France | $0.526B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.504B | 10.91 |
PetIQ (PETQ) | United States | $0.480B | 17.93 |
TerrAscend (TSNDF) | Canada | $0.462B | 0.00 |
ZimVie (ZIMV) | United States | $0.421B | 25.80 |
Biote (BTMD) | United States | $0.416B | 3.96 |
OraSure Technologies (OSUR) | United States | $0.402B | 6.66 |
Surmodics (SRDX) | United States | $0.373B | 40.26 |
Aurora Cannabis (ACB) | Canada | $0.366B | 0.00 |
Zynex (ZYXI) | United States | $0.352B | 40.52 |
Viemed Healthcare (VMD) | United States | $0.310B | 30.81 |
Cerus (CERS) | United States | $0.308B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.266B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.238B | 14.73 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
Omeros (OMER) | United States | $0.177B | 0.00 |
Veru (VERU) | United States | $0.177B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
High Tide (HITI) | Canada | $0.161B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.141B | 70.99 |
FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
InterCure (INCR) | Israel | $0.120B | 20.31 |
Fonar (FONR) | United States | $0.107B | 9.16 |
MariMed (MRMD) | United States | $0.100B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Brainsway (BWAY) | Israel | $0.080B | 0.00 |
Chimerix (CMRX) | United States | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.59 |
Apyx Medical (APYX) | United States | $0.051B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.95 |
Bright Green (BGXX) | United States | $0.035B | 0.00 |
Modular Medical (MODD) | United States | $0.033B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Flora Growth (FLGC) | United States | $0.020B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 74.09 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |